Dr. Burnett is the Marriott Family Professor of Cardiovascular Research, Director of the Cardiorenal Research Laboratory and Mayo Distinguished Investigator. His research has advanced our understanding of humoral mechanisms in heart failure, hypertension and cardiometabolic disease with a special focus on the natriuretic peptide/guanylyl cyclase/cGMP pathway. This research has led to the development of innovative therapeutics and novel diagnostics, which are currently in clinical practice and clinical trials. Dr. Burnett has been continuously funded by the NIH since 1986 and his 585 publications have been published in leading peer review journals such as New England Journal of Medicine, Science, Circulation, Circulation Research, Journal of the American College of Cardiology, American Journal of Physiology, Proceedings of the National Academy of Science, Kidney International, Hypertension, Clinical Chemistry, Journal Molecular and Cellular Cardiology and European Heart Journal. He is a member of the prestigious American Society for Clinical Investigation and Association of American Physicians and was awarded in 2020 the Lifetime Achievement Award by the Heart Failure Society of American. Dr. Burnett holds 32 patents and has contributed to the founding of 3 biotechnology companies.